Ceftriaxone (Sabax-ceftriaxone, Adco Ceftriaxone, Nectram, Ceftriaxone Propan)
Ceftriaxone
Adcock Ingram Critical Care (Pty) Ltd
Registration
- Applicant
- Adcock Ingram Critical Care (Pty) Ltd
- Registrations
- 15
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sabax-ceftriaxone 250 MG EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg | 250 mg | 35030335/20.1.1/0303 | Registered | S4 | None |
| Sabax-ceftriaxone 500 MG EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg | 500 mg | 35030435/20.1.1/0304 | Registered | S4 | None |
| Sabax-ceftriaxone 1 g EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g | 1 g | 35030535/20.1.1/0305 | Registered | S4 | None |
| Sabax-ceftriaxone 2 g EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g | 2 g | 35030635/20.1.1/0306 | Registered | S4 | None |
| Adco ceftriaxone 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg | 500 mg | 37004237/20.1.1/0042 | Registered | S4 | None |
| Adco ceftriaxone 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g | 1 g | 37004337/20.1.1/0043 | Registered | S4 | None |
| Adco ceftriaxone 2 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g | 2 g | 37004437/20.1.1/0044 | Registered | S4 | None |
| Nectram 250 MG Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 250 mg | 250 mg | 52078352/20.1.1/0783 | Registered | S4 | None |
| Nectram 500 MG Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 500 mg | 500 mg | 52078452/20.1.1/0784 | Registered | S4 | None |
| Nectram 1 g Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 1,0 mg | 1 g | 52078552/20.1.1/0785 | Registered | S4 | None |
| Nectram 2 g Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 2 g | 2 g | 52078652/20.1.1/0786 | Registered | S4 | None |
| Ceftriaxone 250 MG propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 250 mg | 250 mg | 52078752/20.1.1/0787 | Cancelled | S4 | None |
| Ceftriaxone 500 MG propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 500 mg | 500 mg | 52078852/20.1.1/0788 | Cancelled | S4 | None |
| Ceftriaxone 1 g propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 1 g | 1 g | 52078952/20.1.1/0789 | Cancelled | S4 | None |
| Ceftriaxone 2 g propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 2 g | 2 g | 52079052/20.1.1/0790 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Ceftriaxone sodium equivalent to ceftriaxone
S4: Ceftriaxone
Consolidated Schedules 06 July 2026, line 5757
Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(6R,7R)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 5479530.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.